Status:
UNKNOWN
Identification of Predictive Biomarkers of Mood Relapses in Patients With Bipolar Disorder
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
Commissariat A L'energie Atomique
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Relapses in bipolar disorders are associated with a significant proportional functional impact, as well as worsening of the course of bipolar disorder, with impairment of the quality of functional rem...
Eligibility Criteria
Inclusion
- Voluntary subjects responding to the diagnosis of bipolar I or II disorder according to the criteria of the DSM-5
- Agreement to benefit from connected objects required for study and able to understand their use
- Age between 18 and75 years old
- Affiliated to the Social Security system (beneficiary or entitled)
- No opposition signed
Exclusion
- Subject included in clinical and/or therapeutic experimentation with exclusion period
- Primary psychiatric pathology other than bipolar type I or II disorder
- Patient hospitalized without consent
- Subject deprived of liberty by judicial or administrative decision
- Pregnant, parturient, breastfeeding woman
- Known allergy to one of the materials of the bracelets
Key Trial Info
Start Date :
January 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04703972
Start Date
January 13 2021
End Date
June 30 2022
Last Update
January 14 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.